Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. This heritage has given us experience and capabilities that also enable us to help people defeat other serious chronic diseases: hemophilia, growth disorders and obesity. Our ambition is to take the lead in each of these areas, driving change with an unfailing belief that it can be done. Producing life-saving medicine is a significant responsibility; however it takes more than that to defeat a serious chronic disease. That is why we work in partnerships with patients, policymakers, healthcare professionals and non-governmental organizations to raise awareness, improve prevention, promote earlier diagnosis and expand access to care.
